Remiges Ventures is a private equity general partner firm headquartered in Cambridge, MA, United States and has other offices in Japan.
French drug developer InFlectis BioScience has raised €6m in a Series A funding round led by CM-CIC Innovation and Remiges Ventures.
Read more news concerning Remiges Ventures
A sampling of Remiges Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?